{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:55:50Z","timestamp":1770501350288,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":421,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.fertnstert.2020.09.158","type":"journal-article","created":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T23:36:58Z","timestamp":1606693018000},"page":"991-1000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Individualized ovarian stimulation for in\u00a0vitro fertilization: a multicenter, open label, exploratory study with a mixed protocol of follitropin delta and highly purified human menopausal gonadotropin"],"prefix":"10.1016","volume":"115","author":[{"given":"Francois","family":"Bissonnette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Minano Masip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac-Jacques","family":"Kadoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford","family":"Librach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Sampalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Yuzpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2020.09.158_bib1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","article-title":"Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in\u00a0vitro fertilization cycles","volume":"101","author":"Steward","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib2","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmm034","article-title":"Evian Annual Reproduction (EVAR) Workshop Group 2007. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation","volume":"14","author":"Fauser","year":"2018","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/ajo.12406","article-title":"Consensus statement on prevention and detection of ovarian hyperstimulation syndrome","volume":"55","author":"Boothroyd","year":"2015","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/17425255.2017.1260546","article-title":"an element of personalized therapy?","volume":"13","author":"Majchrzak-Celi\u0144ska","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fendo.2019.00429","article-title":"The development of gonadotropins for clinical use in the treatment of infertility","volume":"10","author":"Lunenfeld","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/jcph.328","article-title":"Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line","volume":"54","author":"Olsson","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1530\/EC-17-0067","article-title":"Comparative pharmacology of a new recombinant FSH expressed by a human cell line","volume":"6","author":"Koechling","year":"2017","journal-title":"Endocr Connect"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rbmo.2020.07.006","article-title":"Establishing the follitropin delta dose providing a comparable ovarian response as 150 IU\/day follitropin alfa for controlled ovarian stimulation","volume":"41","author":"Arce","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/humrep\/deh625","volume":"20","author":"De Placido","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib11","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.fertnstert.2008.02.137","article-title":"Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin","volume":"91","author":"Gr\u00f8ndahl","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in\u00a0vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Nyboe Andersen","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fendo.2017.00114","article-title":"Efficacy of follicle-stimulating hormone (FSH) alone, FSH\u2009+\u2009luteinizing hormone, human menopausal gonadotropin or FSH\u2009+\u2009human chorionic gonadotropin on assisted reproductive technology outcomes in the \u201cpersonalized\u201d medicine era: a meta-analysis","volume":"8","author":"Santi","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1477-7827-3-61","article-title":"Mixed protocols: multiple ratios of FSH and LH bioactivity using highly purified, human-derived FSH (BRAVELLE) and highly purified hMG (MENOPUR) are unaltered by mixing together in the same syringe","volume":"3","author":"Scobey","year":"2005","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib15","series-title":"Anti-m\u00fcllerian hormone","first-page":"83","article-title":"Using AMH for determining a stratified gonadotrophin dosing regimen for IVF\/ICSI and optimizing outcomes","author":"Arce","year":"2016"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib16","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/humrep\/der037","article-title":"The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting","volume":"26","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1080\/09513590.2019.1600667","article-title":"The impact of adding hp-hMG in r-FSH started GnRH antagonist cycles on ART outcome","volume":"35","author":"Kan","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12522-014-0186-0","article-title":"Comparison of FSH and hMG on ovarian stimulation outcome with a GnRH antagonist protocol in younger and advanced reproductive age women","volume":"14","author":"Tabata","year":"2015","journal-title":"Reprod Med Biol"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pst.1589","article-title":"Use of historical control data for assessing treatment effects in clinical trials","volume":"13","author":"Viele","year":"2014","journal-title":"Pharm Stat"},{"issue":"Suppl 3","key":"10.1016\/j.fertnstert.2020.09.158_bib21","first-page":"S188","article-title":"Ovarian hyperstimulation syndrome","volume":"90","author":"American Society of Reproductive Medicine","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib22","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/humrep\/deu175","article-title":"Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE","volume":"29","author":"Kupka","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.rbmo.2012.11.002","article-title":"GnRH agonist triggering: recent developments","volume":"26","author":"Kol","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2020.09.158_bib24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1701-2163(16)35087-3","article-title":"Advanced reproductive age and fertility","volume":"33","author":"Liu","year":"2011","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028220324006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028220324006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:30:09Z","timestamp":1758011409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028220324006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0015028220324006"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2020.09.158","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individualized ovarian stimulation for in\u00a0vitro fertilization: a multicenter, open label, exploratory study with a mixed protocol of follitropin delta and highly purified human menopausal gonadotropin","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2020.09.158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92020 Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine","name":"copyright","label":"Copyright"}]}}